Compile Data Set for Download or QSAR
maximum 50k data
Found 59 of ic50 data for polymerid = 50003511
TargetPutative sugar transporter(Plasmodium falciparum)
Kadmon

US Patent
LigandPNGBDBM453253(2-(3-(4-((4-(1H-pyrazol-4-yl)phenyl)amino)-6-methy...)
Affinity DataIC50:  55nMAssay Description:Parasite cultures were seeded in 96-well plates (1% hematocrit, 1-2% starting parasitemia, 100 μL total volume) with varying concentrations of t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPutative sugar transporter(Plasmodium falciparum)
Kadmon

US Patent
LigandPNGBDBM453270(2-(3-(4-((4-(1H-pyrazol-4-yl)phenyl)amino)-6-acety...)
Affinity DataIC50:  55nMAssay Description:Parasite cultures were seeded in 96-well plates (1% hematocrit, 1-2% starting parasitemia, 100 μL total volume) with varying concentrations of t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPutative sugar transporter(Plasmodium falciparum)
Kadmon

US Patent
LigandPNGBDBM453256(2-(3-(4-((4-(1H-pyrazol-4-yl)phenyl)amino)-7,8-dih...)
Affinity DataIC50:  55nMAssay Description:Parasite cultures were seeded in 96-well plates (1% hematocrit, 1-2% starting parasitemia, 100 μL total volume) with varying concentrations of t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPutative sugar transporter(Plasmodium falciparum)
Kadmon

US Patent
LigandPNGBDBM453258(2-(3-(4-((4-(1H-pyrazol-4-yl)phenyl)amino)thieno[3...)
Affinity DataIC50:  55nMAssay Description:Parasite cultures were seeded in 96-well plates (1% hematocrit, 1-2% starting parasitemia, 100 μL total volume) with varying concentrations of t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPutative sugar transporter(Plasmodium falciparum)
Kadmon

US Patent
LigandPNGBDBM453231(2-(3-(4-((4-(1H-pyrazol-4-yl)phenyl)amino)-1-methy...)
Affinity DataIC50:  55nMAssay Description:Parasite cultures were seeded in 96-well plates (1% hematocrit, 1-2% starting parasitemia, 100 μL total volume) with varying concentrations of t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPutative sugar transporter(Plasmodium falciparum)
Kadmon

US Patent
LigandPNGBDBM453216(2-(3-(4-((4-(1H-pyrazol-4-yl)phenyl)amino)-6-isobu...)
Affinity DataIC50:  55nMAssay Description:Parasite cultures were seeded in 96-well plates (1% hematocrit, 1-2% starting parasitemia, 100 μL total volume) with varying concentrations of t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPutative sugar transporter(Plasmodium falciparum)
Kadmon

US Patent
LigandPNGBDBM453263(2-(3-(4-((4-(1H-pyrazol-4-yl)phenyl)amino)-6-acety...)
Affinity DataIC50:  55nMAssay Description:Parasite cultures were seeded in 96-well plates (1% hematocrit, 1-2% starting parasitemia, 100 μL total volume) with varying concentrations of t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPutative sugar transporter(Plasmodium falciparum)
Kadmon

US Patent
LigandPNGBDBM453243(2-(3-(4-((4-(1H-pyrazol-4-yl)phenyl)amino)-5,7-dih...)
Affinity DataIC50:  55nMAssay Description:Parasite cultures were seeded in 96-well plates (1% hematocrit, 1-2% starting parasitemia, 100 μL total volume) with varying concentrations of t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPutative sugar transporter(Plasmodium falciparum)
Kadmon

US Patent
LigandPNGBDBM453242(2-(3-(4-((4-(1H-pyrazol-4-yl)phenyl)amino)-5,7-dih...)
Affinity DataIC50:  55nMAssay Description:Parasite cultures were seeded in 96-well plates (1% hematocrit, 1-2% starting parasitemia, 100 μL total volume) with varying concentrations of t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPutative sugar transporter(Plasmodium falciparum)
Kadmon

US Patent
LigandPNGBDBM453222(US10729691, Example 7)
Affinity DataIC50:  55nMAssay Description:Parasite cultures were seeded in 96-well plates (1% hematocrit, 1-2% starting parasitemia, 100 μL total volume) with varying concentrations of t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPutative sugar transporter(Plasmodium falciparum)
Kadmon

US Patent
LigandPNGBDBM453259(2-(3-(4-((4-(1H-pyrazol-4-yl)phenyl)amino)-6-acety...)
Affinity DataIC50:  55nMAssay Description:Parasite cultures were seeded in 96-well plates (1% hematocrit, 1-2% starting parasitemia, 100 μL total volume) with varying concentrations of t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPutative sugar transporter(Plasmodium falciparum)
Kadmon

US Patent
LigandPNGBDBM453260(2-(3-(4-((4-(1H-pyrazol-4-yl)phenyl)amino)-6-acety...)
Affinity DataIC50:  55nMAssay Description:Parasite cultures were seeded in 96-well plates (1% hematocrit, 1-2% starting parasitemia, 100 μL total volume) with varying concentrations of t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPutative sugar transporter(Plasmodium falciparum)
Kadmon

US Patent
LigandPNGBDBM453261(2-(3-(4-((4-(1H-pyrazol-4-yl)phenyl)amino)-7,8-dih...)
Affinity DataIC50:  55nMAssay Description:Parasite cultures were seeded in 96-well plates (1% hematocrit, 1-2% starting parasitemia, 100 μL total volume) with varying concentrations of t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPutative sugar transporter(Plasmodium falciparum)
Kadmon

US Patent
LigandPNGBDBM453262(2-(3-(4-((4-(1H-pyrazol-4-yl)phenyl)amino)-7,8-dih...)
Affinity DataIC50:  55nMAssay Description:Parasite cultures were seeded in 96-well plates (1% hematocrit, 1-2% starting parasitemia, 100 μL total volume) with varying concentrations of t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPutative sugar transporter(Plasmodium falciparum)
Kadmon

US Patent
LigandPNGBDBM453221(US10729691, Example 6)
Affinity DataIC50:  55nMAssay Description:Parasite cultures were seeded in 96-well plates (1% hematocrit, 1-2% starting parasitemia, 100 μL total volume) with varying concentrations of t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPutative sugar transporter(Plasmodium falciparum)
Kadmon

US Patent
LigandPNGBDBM453265(2-(3-(4-((4-(1H-pyrazol-4-yl)phenyl)amino)-7,8-dih...)
Affinity DataIC50:  55nMAssay Description:Parasite cultures were seeded in 96-well plates (1% hematocrit, 1-2% starting parasitemia, 100 μL total volume) with varying concentrations of t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPutative sugar transporter(Plasmodium falciparum)
Kadmon

US Patent
LigandPNGBDBM453264(2-(3-(4-((4-(1H-pyrazol-4-yl)phenyl)amino)-7,8-dih...)
Affinity DataIC50:  55nMAssay Description:Parasite cultures were seeded in 96-well plates (1% hematocrit, 1-2% starting parasitemia, 100 μL total volume) with varying concentrations of t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPutative sugar transporter(Plasmodium falciparum)
Kadmon

US Patent
LigandPNGBDBM453233(2-(3-(4-((4-(1H-pyrazol-4-yl)phenyl)amino)-1-methy...)
Affinity DataIC50:  55nMAssay Description:Parasite cultures were seeded in 96-well plates (1% hematocrit, 1-2% starting parasitemia, 100 μL total volume) with varying concentrations of t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPutative sugar transporter(Plasmodium falciparum)
Kadmon

US Patent
LigandPNGBDBM453255(2-(3-(4-((4-(1H-pyrazol-4-yl)phenyl)amino)-7,8-dih...)
Affinity DataIC50:  55nMAssay Description:Parasite cultures were seeded in 96-well plates (1% hematocrit, 1-2% starting parasitemia, 100 μL total volume) with varying concentrations of t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPutative sugar transporter(Plasmodium falciparum)
Kadmon

US Patent
LigandPNGBDBM453246(2-(3-(4-((4-(1H-pyrazol-4-yl)phenyl)amino)-5,7-dih...)
Affinity DataIC50:  175nMAssay Description:Parasite cultures were seeded in 96-well plates (1% hematocrit, 1-2% starting parasitemia, 100 μL total volume) with varying concentrations of t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPutative sugar transporter(Plasmodium falciparum)
Kadmon

US Patent
LigandPNGBDBM453245(2-(3-(4-((4-(1H-pyrazol-4-yl)phenyl)amino)-5,7-dih...)
Affinity DataIC50:  175nMAssay Description:Parasite cultures were seeded in 96-well plates (1% hematocrit, 1-2% starting parasitemia, 100 μL total volume) with varying concentrations of t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPutative sugar transporter(Plasmodium falciparum)
Kadmon

US Patent
LigandPNGBDBM453244(2-(3-(4-((4-(1H-pyrazol-4-yl)phenyl)amino)-5,7-dih...)
Affinity DataIC50:  175nMAssay Description:Parasite cultures were seeded in 96-well plates (1% hematocrit, 1-2% starting parasitemia, 100 μL total volume) with varying concentrations of t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPutative sugar transporter(Plasmodium falciparum)
Kadmon

US Patent
LigandPNGBDBM453241(2-(3-(4-((4-(1H-pyrazol-4-yl)phenyl)amino)-5,7-dih...)
Affinity DataIC50:  175nMAssay Description:Parasite cultures were seeded in 96-well plates (1% hematocrit, 1-2% starting parasitemia, 100 μL total volume) with varying concentrations of t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPutative sugar transporter(Plasmodium falciparum)
Kadmon

US Patent
LigandPNGBDBM453236(2-(3-(4-((4-(1H-pyrazol-4-yl)phenyl)amino)pyrido[3...)
Affinity DataIC50:  175nMAssay Description:Parasite cultures were seeded in 96-well plates (1% hematocrit, 1-2% starting parasitemia, 100 μL total volume) with varying concentrations of t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPutative sugar transporter(Plasmodium falciparum)
Kadmon

US Patent
LigandPNGBDBM453235(2-(3-(4-((4-(1H-pyrazol-4-yl)phenyl)amino)pyrido[3...)
Affinity DataIC50:  175nMAssay Description:Parasite cultures were seeded in 96-well plates (1% hematocrit, 1-2% starting parasitemia, 100 μL total volume) with varying concentrations of t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPutative sugar transporter(Plasmodium falciparum)
Kadmon

US Patent
LigandPNGBDBM453234(2-(3-(4-((4-(1H-pyrazol-4-yl)phenyl)amino)pyrido[3...)
Affinity DataIC50:  175nMAssay Description:Parasite cultures were seeded in 96-well plates (1% hematocrit, 1-2% starting parasitemia, 100 μL total volume) with varying concentrations of t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPutative sugar transporter(Plasmodium falciparum)
Kadmon

US Patent
LigandPNGBDBM453232(2-(3-(4-((4-(1H-pyrazol-4-yl)phenyl)amino)-1-methy...)
Affinity DataIC50:  175nMAssay Description:Parasite cultures were seeded in 96-well plates (1% hematocrit, 1-2% starting parasitemia, 100 μL total volume) with varying concentrations of t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPutative sugar transporter(Plasmodium falciparum)
Kadmon

US Patent
LigandPNGBDBM453230(2-(3-(4-((4-(1H-pyrazol-4-yl)phenyl)amino)-1-methy...)
Affinity DataIC50:  175nMAssay Description:Parasite cultures were seeded in 96-well plates (1% hematocrit, 1-2% starting parasitemia, 100 μL total volume) with varying concentrations of t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPutative sugar transporter(Plasmodium falciparum)
Kadmon

US Patent
LigandPNGBDBM453228(US10729691, Example 13)
Affinity DataIC50:  175nMAssay Description:Parasite cultures were seeded in 96-well plates (1% hematocrit, 1-2% starting parasitemia, 100 μL total volume) with varying concentrations of t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPutative sugar transporter(Plasmodium falciparum)
Kadmon

US Patent
LigandPNGBDBM453227(US10729691, Example 12)
Affinity DataIC50:  175nMAssay Description:Parasite cultures were seeded in 96-well plates (1% hematocrit, 1-2% starting parasitemia, 100 μL total volume) with varying concentrations of t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPutative sugar transporter(Plasmodium falciparum)
Kadmon

US Patent
LigandPNGBDBM453226(US10729691, Example 11)
Affinity DataIC50:  175nMAssay Description:Parasite cultures were seeded in 96-well plates (1% hematocrit, 1-2% starting parasitemia, 100 μL total volume) with varying concentrations of t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPutative sugar transporter(Plasmodium falciparum)
Kadmon

US Patent
LigandPNGBDBM453225(US10729691, Example 10)
Affinity DataIC50:  175nMAssay Description:Parasite cultures were seeded in 96-well plates (1% hematocrit, 1-2% starting parasitemia, 100 μL total volume) with varying concentrations of t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPutative sugar transporter(Plasmodium falciparum)
Kadmon

US Patent
LigandPNGBDBM453223(US10729691, Example 8)
Affinity DataIC50:  175nMAssay Description:Parasite cultures were seeded in 96-well plates (1% hematocrit, 1-2% starting parasitemia, 100 μL total volume) with varying concentrations of t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPutative sugar transporter(Plasmodium falciparum)
Kadmon

US Patent
LigandPNGBDBM453218(US10729691, Example 3)
Affinity DataIC50:  175nMAssay Description:Parasite cultures were seeded in 96-well plates (1% hematocrit, 1-2% starting parasitemia, 100 μL total volume) with varying concentrations of t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPutative sugar transporter(Plasmodium falciparum)
Kadmon

US Patent
LigandPNGBDBM453274(2-(3-(4-((4-(1H-pyrazol-4-yl)phenyl)amino)-6-acety...)
Affinity DataIC50:  175nMAssay Description:Parasite cultures were seeded in 96-well plates (1% hematocrit, 1-2% starting parasitemia, 100 μL total volume) with varying concentrations of t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPutative sugar transporter(Plasmodium falciparum)
Kadmon

US Patent
LigandPNGBDBM453217(2-(3-(4-((4-(1H-pyrazol-4-yl)phenyl)amino)-5,7-dih...)
Affinity DataIC50:  175nMAssay Description:Parasite cultures were seeded in 96-well plates (1% hematocrit, 1-2% starting parasitemia, 100 μL total volume) with varying concentrations of t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPutative sugar transporter(Plasmodium falciparum)
Kadmon

US Patent
LigandPNGBDBM453273(2-(3-(4-((4-(1H-pyrazol-4-yl)phenyl)amino)pyrido[4...)
Affinity DataIC50:  175nMAssay Description:Parasite cultures were seeded in 96-well plates (1% hematocrit, 1-2% starting parasitemia, 100 μL total volume) with varying concentrations of t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPutative sugar transporter(Plasmodium falciparum)
Kadmon

US Patent
LigandPNGBDBM453272(2-(3-(4-((4-(1H-pyrazol-4-yl)phenyl)amino)-6-acety...)
Affinity DataIC50:  175nMAssay Description:Parasite cultures were seeded in 96-well plates (1% hematocrit, 1-2% starting parasitemia, 100 μL total volume) with varying concentrations of t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPutative sugar transporter(Plasmodium falciparum)
Kadmon

US Patent
LigandPNGBDBM453271(2-(3-(4-((4-(1H-pyrazol-4-yl)phenyl)amino)-6-acety...)
Affinity DataIC50:  175nMAssay Description:Parasite cultures were seeded in 96-well plates (1% hematocrit, 1-2% starting parasitemia, 100 μL total volume) with varying concentrations of t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPutative sugar transporter(Plasmodium falciparum)
Kadmon

US Patent
LigandPNGBDBM453268(2-(3-(4-((4-(1H-pyrazol-4-yl)phenyl)amino)pyrido[4...)
Affinity DataIC50:  175nMAssay Description:Parasite cultures were seeded in 96-well plates (1% hematocrit, 1-2% starting parasitemia, 100 μL total volume) with varying concentrations of t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPutative sugar transporter(Plasmodium falciparum)
Kadmon

US Patent
LigandPNGBDBM453267(2-(3-(4-((4-(1H-pyrazol-4-yl)phenyl)amino)-7,8-dih...)
Affinity DataIC50:  175nMAssay Description:Parasite cultures were seeded in 96-well plates (1% hematocrit, 1-2% starting parasitemia, 100 μL total volume) with varying concentrations of t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPutative sugar transporter(Plasmodium falciparum)
Kadmon

US Patent
LigandPNGBDBM453266(2-(3-(4-((4-(1H-pyrazol-4-yl)phenyl)amino)-7,8-dih...)
Affinity DataIC50:  175nMAssay Description:Parasite cultures were seeded in 96-well plates (1% hematocrit, 1-2% starting parasitemia, 100 μL total volume) with varying concentrations of t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPutative sugar transporter(Plasmodium falciparum)
Kadmon

US Patent
LigandPNGBDBM453257(2-(3-(4-((4-(1H-pyrazol-4-yl)phenyl)amino)thieno[3...)
Affinity DataIC50:  175nMAssay Description:Parasite cultures were seeded in 96-well plates (1% hematocrit, 1-2% starting parasitemia, 100 μL total volume) with varying concentrations of t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPutative sugar transporter(Plasmodium falciparum)
Kadmon

US Patent
LigandPNGBDBM453254(2-(3-(4-((4-(1H-pyrazol-4-yl)phenyl)amino)-6-methy...)
Affinity DataIC50:  175nMAssay Description:Parasite cultures were seeded in 96-well plates (1% hematocrit, 1-2% starting parasitemia, 100 μL total volume) with varying concentrations of t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPutative sugar transporter(Plasmodium falciparum)
Kadmon

US Patent
LigandPNGBDBM453252(2-(3-(4-((4-(1H-pyrazol-4-yl)phenyl)amino)-6-methy...)
Affinity DataIC50:  175nMAssay Description:Parasite cultures were seeded in 96-well plates (1% hematocrit, 1-2% starting parasitemia, 100 μL total volume) with varying concentrations of t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPutative sugar transporter(Plasmodium falciparum)
Kadmon

US Patent
LigandPNGBDBM453238(2-(3-(7-((4-(1H-pyrazol-4-yl)phenyl)amino)thiazolo...)
Affinity DataIC50:  375nMAssay Description:Parasite cultures were seeded in 96-well plates (1% hematocrit, 1-2% starting parasitemia, 100 μL total volume) with varying concentrations of t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPutative sugar transporter(Plasmodium falciparum)
Kadmon

US Patent
LigandPNGBDBM453237(2-(3-(7-((4-(1H-pyrazol-4-yl)phenyl)amino)thiazolo...)
Affinity DataIC50:  375nMAssay Description:Parasite cultures were seeded in 96-well plates (1% hematocrit, 1-2% starting parasitemia, 100 μL total volume) with varying concentrations of t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPutative sugar transporter(Plasmodium falciparum)
Kadmon

US Patent
LigandPNGBDBM453229(2-(3-(4-((4-(1H-pyrazol-4-yl)phenyl)amino)pyrido[3...)
Affinity DataIC50:  375nMAssay Description:Parasite cultures were seeded in 96-well plates (1% hematocrit, 1-2% starting parasitemia, 100 μL total volume) with varying concentrations of t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPutative sugar transporter(Plasmodium falciparum)
Kadmon

US Patent
LigandPNGBDBM453224(US10729691, Example 9)
Affinity DataIC50:  375nMAssay Description:Parasite cultures were seeded in 96-well plates (1% hematocrit, 1-2% starting parasitemia, 100 μL total volume) with varying concentrations of t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPutative sugar transporter(Plasmodium falciparum)
Kadmon

US Patent
LigandPNGBDBM453239(2-(3-(7-((4-(1H-pyrazol-4-yl)phenyl)amino)thiazolo...)
Affinity DataIC50:  375nMAssay Description:Parasite cultures were seeded in 96-well plates (1% hematocrit, 1-2% starting parasitemia, 100 μL total volume) with varying concentrations of t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Displayed 1 to 50 (of 59 total ) | Next | Last >>
Jump to: